Researchers at Trinity have found that a largely overlooked form of cancer evolution, which drives aggressive disease and ...
Cancer does not develop overnight. It can take decades for cancer‐promoting changes in the genome to eventually lead to the formation of a malignant tumor. Researchers at the German Cancer Research ...
Cancer does not develop overnight. It can take decades for cancer-promoting changes in the genome to eventually lead to the formation of a malignant tumor. Researchers at the German Cancer Research ...
EVOFLUx uses DNA methylation fluctuations as molecular barcodes to trace tumor evolution, offering insights into growth, treatment resistance, and prognosis. The method requires only bulk methylation ...
Serial circulating tumor DNA analysis can demonstrate rapid clonal dynamics that evolve during response and resistance to both standard chemotherapy and targeted therapy of BRAF-mutant colon cancer ...
Available in electronic full text to members of the University via the Library web catalogue. ELEC copy purchased with funds from the S. Dillon Ripley Endowment A fundamental and groundbreaking ...
Real-world clinical outcome of sacituzumab govitecan (SG) in HER2-negative metastatic breast cancer. Assessing venous thromboembolism risk in HR+/HER2- breast cancer patients receiving CDK4/6 ...
The authors created detailed 3D renderings of tumors from more than 2,000 individuals, with breast, colon, pancreatic, kidney and uterine cancers, among others. From these detailed atlases, the ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Benjamin L.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results